"The NCCN Guidelines are widely recognized as a key indicator of standards of excellence for cancer care and prevention. We believe the current alignment between these highly influential cancer ...

RET fusion-positive NSCLC patients benefit from targeted therapies like Retevmo and Gavreto, recommended by NCCN guidelines for first-line treatment. Gavreto demonstrated a 57% overall response rate ...

The NCCN Annual Conference brings together leading minds and subject matter experts in front of a multidisciplinary audience to share the latest recommendations for cancer treatment and prevention.

Reid, MSPH, PhD, Chief of Cancer Screening, Survivorship and Mentorship at Roswell Park Comprehensive Cancer Center, a Member of the NCCN Guidelines Panel for Lung Cancer Screening. The conference ...

New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with ...

Megan Meyer is a science communication consultant who is passionate about translating science to a variety of audiences. She received her PhD in nutritional immunology from The University of North ...

Akriti Jain, MD, discussed how emerging data on non-ABL1 mutations is reshaping chronic myeloid leukemia management.

For example, L-Dex testing is recognized in clinical guidelines and by national accreditation programs and is a proven method for preventing lymphedema from progressing to a chronic condition. By ...

Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously and managed expectantly by monitoring the patient's complete blood count. Over several months ...